- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03327324
Improving Sleep Using Mentored Behavioral and Environmental Restructuring (SLUMBER)
January 10, 2023 updated by: NYU Langone Health
The goal of this study is to test potential functional/psychosocial benefits of improved sleep using a program designed to teach nursing facility staff to improve sleep promoting strategies and environment for nursing home residents.
Sleep disturbances are quite common in skilled nursing facilities and affect as many as 69% of residents while staff do not fully understand how to improve sleep without using medications.
Medications for sleep are commonly used as first-line therapy for older adults but this is problematic because these medications can lead to greater problems with thinking, more frequent falls, and even worse sleep over time.
In addition, poor sleep can lead to depressed mood, greater trouble with thinking and memory, worse pain, and greater need for help with daily activities.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a study to test the effects of improved sleep quality on downstream functional/psychosocial outcomes.
Study Type
Interventional
Enrollment (Actual)
110
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- New York University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- living in the unit of intervention,
- ability to communicate and follow simple commands,
- English- or Spanish-speaking,
- capacity to consent assessed with standard questions used to assess capacity or having a surrogate who can provide consent.
Exclusion Criteria:
- Does not have capacity and does not show enthusiasm for the research
- Does not have capacity and does not have a proxy.
- obtunded or comatose state,
- inability to communicate verbally,
- inability to consent and without surrogate
- non-English and non-Spanish speaking. In keeping with QI strategies, all residents will be exposed to the environmental aspects of the intervention, as these strategies represent clinically proven non-experimental behavioral strategies with no perceptible harm.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: SEQUENTIAL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: F1U1
Sequence 1 (Facility 1/Unit 1): Baseline, then 3 Month SLUMBER Intervention, then 39 Month Sustainability.
|
SLUMBER is a non-pharmacological intervention program, delivered by providing mentoring to facility staff who work directly with residents.
SLUMBER focuses on detecting sleep-disruptive factors including: nighttime noise and patient behaviors associated with poor sleep quality; disruptions caused by nighttime caregiving; daytime inactivity; and limited light exposure.
In this model, staff-delivered interventions to improve these factors improve sleep quality thereby creating opportunities to test the impact of improving sleep quality (measured by actigraphy) on mood (depression and anxiety), pain, cognitive function, functional ability, and observed activity levels.
Other Names:
|
|
EXPERIMENTAL: F1U2
Sequence 2 (Facility 1/Unit 2): Baseline, then 3 Month SLUMBER Intervention, then 33 Month Sustainability
|
SLUMBER is a non-pharmacological intervention program, delivered by providing mentoring to facility staff who work directly with residents.
SLUMBER focuses on detecting sleep-disruptive factors including: nighttime noise and patient behaviors associated with poor sleep quality; disruptions caused by nighttime caregiving; daytime inactivity; and limited light exposure.
In this model, staff-delivered interventions to improve these factors improve sleep quality thereby creating opportunities to test the impact of improving sleep quality (measured by actigraphy) on mood (depression and anxiety), pain, cognitive function, functional ability, and observed activity levels.
Other Names:
|
|
EXPERIMENTAL: F2U2
Sequence 3 (Facility 2/Unit 2): Baseline, then 3 Month SLUMBER Intervention, then 27 Month Sustainability
|
SLUMBER is a non-pharmacological intervention program, delivered by providing mentoring to facility staff who work directly with residents.
SLUMBER focuses on detecting sleep-disruptive factors including: nighttime noise and patient behaviors associated with poor sleep quality; disruptions caused by nighttime caregiving; daytime inactivity; and limited light exposure.
In this model, staff-delivered interventions to improve these factors improve sleep quality thereby creating opportunities to test the impact of improving sleep quality (measured by actigraphy) on mood (depression and anxiety), pain, cognitive function, functional ability, and observed activity levels.
Other Names:
|
|
EXPERIMENTAL: F2U3
Sequence 4 (Facility 2/Unit 3): Baseline, then 3 Month SLUMBER Intervention, then 21 Month Sustainability
|
SLUMBER is a non-pharmacological intervention program, delivered by providing mentoring to facility staff who work directly with residents.
SLUMBER focuses on detecting sleep-disruptive factors including: nighttime noise and patient behaviors associated with poor sleep quality; disruptions caused by nighttime caregiving; daytime inactivity; and limited light exposure.
In this model, staff-delivered interventions to improve these factors improve sleep quality thereby creating opportunities to test the impact of improving sleep quality (measured by actigraphy) on mood (depression and anxiety), pain, cognitive function, functional ability, and observed activity levels.
Other Names:
|
|
EXPERIMENTAL: F2U4
Sequence 5 (Facility 2/Unit 4): Baseline, then 3 Month SLUMBER Intervention, then 15 Month Sustainability
|
SLUMBER is a non-pharmacological intervention program, delivered by providing mentoring to facility staff who work directly with residents.
SLUMBER focuses on detecting sleep-disruptive factors including: nighttime noise and patient behaviors associated with poor sleep quality; disruptions caused by nighttime caregiving; daytime inactivity; and limited light exposure.
In this model, staff-delivered interventions to improve these factors improve sleep quality thereby creating opportunities to test the impact of improving sleep quality (measured by actigraphy) on mood (depression and anxiety), pain, cognitive function, functional ability, and observed activity levels.
Other Names:
|
|
EXPERIMENTAL: F3U1
Sequence 6 (Facility 3/Unit 1): Baseline, then 3 Month SLUMBER Intervention, then 9 Month Sustainability
|
SLUMBER is a non-pharmacological intervention program, delivered by providing mentoring to facility staff who work directly with residents.
SLUMBER focuses on detecting sleep-disruptive factors including: nighttime noise and patient behaviors associated with poor sleep quality; disruptions caused by nighttime caregiving; daytime inactivity; and limited light exposure.
In this model, staff-delivered interventions to improve these factors improve sleep quality thereby creating opportunities to test the impact of improving sleep quality (measured by actigraphy) on mood (depression and anxiety), pain, cognitive function, functional ability, and observed activity levels.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep Efficiency (SE)
Time Frame: Baseline
|
Sleep efficiency (SE), commonly defined as the ratio of total sleep time (TST) to time in bed (TIB), will be reported as a percentage of time in bed.
This data will be obtained from actigraphy analysis.
|
Baseline
|
|
Sleep Efficiency (SE)
Time Frame: Post-Treatment (Month 6 Post-Baseline)
|
Sleep efficiency (SE), commonly defined as the ratio of total sleep time (TST) to time in bed (TIB), will be reported as a percentage of time in bed.
This data will be obtained from actigraphy analysis.
|
Post-Treatment (Month 6 Post-Baseline)
|
|
Sleep Efficiency (SE)
Time Frame: Month 9 Post-Baseline
|
Sleep efficiency (SE), commonly defined as the ratio of total sleep time (TST) to time in bed (TIB), will be reported as a percentage of time in bed.
This data will be obtained from actigraphy analysis.
|
Month 9 Post-Baseline
|
|
Nighttime Total Awake Time
Time Frame: Baseline
|
Data will be obtained from antigraphy analysis.
|
Baseline
|
|
Nighttime Total Awake Time
Time Frame: Post-Treatment (Month 6 Post-Baseline)
|
Data will be obtained from antigraphy analysis.
|
Post-Treatment (Month 6 Post-Baseline)
|
|
Nighttime Total Awake Time
Time Frame: Month 9 Post-Baseline
|
Data will be obtained from antigraphy analysis.
|
Month 9 Post-Baseline
|
|
Daytime Sleeping (Napping) Time
Time Frame: Baseline
|
Wrist device / actigraphy will be used to measure sleep/wake time.
|
Baseline
|
|
Daytime Sleeping (Napping) Time
Time Frame: Post-Treatment (Month 6 Post-Baseline)
|
Wrist device / actigraphy will be used to measure sleep/wake time.
|
Post-Treatment (Month 6 Post-Baseline)
|
|
Daytime Sleeping (Napping) Time
Time Frame: Month 9 Post-Baseline
|
Wrist device / actigraphy will be used to measure sleep/wake time.
|
Month 9 Post-Baseline
|
|
Score on Pittsburgh Sleep Quality Index (PSQI)
Time Frame: Month 9 Post-Baseline
|
PSQI contains 19 self-rated questions.
The 19 questions are combined to form seven "component" scores, each of which has a range of 0-3 points.
In all cases, a score of "0" indicates no difficulty, while a score of "3" indicates severe difficulty.
The total score range is 0-21; the higher the score, the greater the difficulties in all areas.
|
Month 9 Post-Baseline
|
|
Brief Anxiety and Depression Scale (BADS) Questionnaire Score
Time Frame: Month 9 Post-Baseline
|
BADS is a brief screening tool for mood impairment developed for older adults.
It consists of 8 questions, answered 0 (no), 1(somewhat), or 2 (yes).
The total score range is 0-16; the higher the score, the higher the level of mood impairment
|
Month 9 Post-Baseline
|
|
Score on Brief Cognitive Assessment Tool (BCAT)
Time Frame: Month 9 Post-Baseline
|
BCAT is a multi-domain cognitive instrument that assesses orientation, verbal recall, visual recognition, visual recall, attention, abstraction, language, executive functions, and visuo-spatial processing in adult and older adult populations.
It consists of 21 items.
The total score range is 0-50; the higher the score, the more normal the level of cognitive functioning and independent living.
|
Month 9 Post-Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 27, 2018
Primary Completion (ACTUAL)
February 23, 2021
Study Completion (ACTUAL)
February 23, 2021
Study Registration Dates
First Submitted
October 25, 2017
First Submitted That Met QC Criteria
October 26, 2017
First Posted (ACTUAL)
October 31, 2017
Study Record Updates
Last Update Posted (ACTUAL)
February 8, 2023
Last Update Submitted That Met QC Criteria
January 10, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 17-00338
- 1R01NR016461-01A1 (NIH)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
Christoph NissenRecruitingInsomnia | Insomnia Chronic | Insomnia Disorder | Insomnia, Primary | Insomnia Type; Sleep Disorder | Insomnia Disorders | Insomnia, NonorganicSwitzerland
-
University of PennsylvaniaPatient-Centered Outcomes Research InstituteNot yet recruitingInsomnia | Chronic Insomnia | Insomnia Disorder | Chronic Insomnia DisorderUnited States
-
University of California, San FranciscoCompleted
-
VA Office of Research and DevelopmentVA Connecticut Healthcare System; US Department of Veterans AffairsCompleted
-
Weill Medical College of Cornell UniversityWeill Cornell Medical College in QatarWithdrawn
-
Eisai Inc.CompletedInsomniaUnited States
-
SanofiCompletedInsomniaUnited States
-
National Yang Ming UniversityBened Biomedical Co., Ltd.Recruiting
-
Leiden University Medical CenterCompleted
Clinical Trials on Sleep Using Mentored Behavioral and Environmental Restructuring
-
Virginia Polytechnic Institute and State UniversityCompleted
-
University of BolognaIRCCS Azienda Ospedaliero-Universitaria di Bologna; European UnionCompleted
-
Research Institute of Child Nutrition, DortmundCompleted
-
University of VirginiaUniversity of Pittsburgh; National Center for Advancing Translational Sciences...CompletedInsomnia | Sleep Initiation and Maintenance Disorders | Family CaregiversUnited States
-
University of ChicagoCompletedAnger | Intermittent Explosive DisorderUnited States
-
MICHAEL A GRANDNERUniversity of PennsylvaniaTerminatedSleep Initiation and Maintenance Disorders | Suicidal IdeationUnited States
-
Matthew Southward, PhDNational Institute of Mental Health (NIMH)RecruitingDepression | Obsessive-Compulsive Disorder | Anxiety | Borderline Personality Disorder | Posttraumatic Stress Disorder | Eating Disorders | Emotional RegulationUnited States
-
University of South FloridaNational Institute on Aging (NIA)CompletedCaregivers of Persons With DementiaUnited States
-
University of Sao PauloCompleted
-
University of Beira InteriorRecruitingSleep Disorder | Obesity and OverweightPortugal